With regard to this synergy, in PC-3—the cell lines of human prostate cancer—quercetin and 2-methoxyestradiol display antiproliferative and proapoptotic activity by growing the Stage G2/M of the cell population and decreasing Bcl-2/Bax. Here, BCL2 is linked to prostate cancer.